Graphite Bio is a next-generation gene editing company focused on targeted DNA integration to precisely insert genetic payloads to treat a variety of severe diseases.

Company Name

Graphite Bio (GRPH)

Location

South San Francisco, CA

Investment Stage

IPO June 2021